Epithalon
Epithalon Research Overview: AEDG Tetrapeptide and Cellular-Aging Models
Epithalon, also written Epitalon or AEDG, is a short tetrapeptide discussed in pineal-peptide, gene-expression and cellular-aging research contexts.
Names and sequence identity
Epithalon is also commonly written as Epitalon or discussed by the short sequence label AEDG. AEDG refers to the four-residue sequence Ala-Glu-Asp-Gly.
As a tetrapeptide, Epithalon is structurally compact. Its identity is tied closely to residue order and exact naming.
Research-use only: the material is supplied for laboratory research, not for human or veterinary administration.
Pineal-peptide research context
Epithalon appears in literature connected to pineal peptide preparations, gene-expression studies and experimental gerontology models.
Those research areas can involve cell culture, animal models or molecular markers. They should not be translated into anti-aging claims or expected outcomes in humans.
Cellular-aging language
Cellular-aging research may discuss telomere biology, gene expression, oxidative stress or cell-state markers. These are laboratory endpoints, not consumer benefit claims.
A responsible overview should explain why the compound is discussed in those models while keeping the product status research-use only.
Quality markers
For a short peptide such as AEDG, sequence identity, molecular weight, HPLC purity and batch traceability are practical quality markers.
Short length does not remove the need for analytical checks. A small peptide can still have impurities, salts, degradation products or labeling ambiguity.
Research-use boundary
Unauthorized human-use risk context
This section is a safety boundary, not application guidance. The material is not supplied for human or veterinary administration, and the points below do not describe expected effects or acceptable use.
- Research-use material has not been supplied as a finished pharmaceutical product, so unauthorized human use can involve unknown identity, impurity, sterility, immune-response and contamination risks.
- Because Epithalon is discussed in gene-expression and cellular-aging models, unauthorized human use could involve unknown risks around cell-state signaling, endocrine context or off-target biological responses.
- If a non-sterile or improperly characterized material were introduced into the body, possible risks include infection, inflammatory reactions, fever-like responses, local tissue irritation and other serious adverse events.
Keep reading
Related research context
FAQ
Common questions
Are Epithalon, Epitalon and AEDG the same naming area?
They are commonly used around the same tetrapeptide context. AEDG describes the four-residue sequence Ala-Glu-Asp-Gly.
Can this page make anti-aging claims?
No. It can describe cellular-aging research contexts, but it must not make consumer benefit, treatment or human-outcome claims.
Does short peptide length remove quality concerns?
No. Short peptides still require identity, purity and batch-traceability checks.
